Binding characteristics of SLE anti-DNA autoantibodies to catecholestrogen-modified DNA

Scandinavian Journal of Immunology

Volumn 64, Issue 6, 2006, Pages 677-683

  Khan, W A ^a   Moinuddin, ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYESTRADIOL; AGAROSE; AUTOANTIBODY; CATECHOL ESTROGEN; DNA ANTIBODY; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; NITRIC OXIDE; PLASMID DNA; POLYMER; PRECIPITIN; PROTEIN A;

ADULT; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN INDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; AUTOANTIBODIES; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ESTRADIOL; ESTROGENS, CATECHOL; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 33750726981     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.01855.x     Document Type: Article

References (40)

1. Jacobson DL, Gange SJ, Rose NR, Graham NMH. Epidemiology and estimated population burden of selected autoimmune disease in the United States. Clin Immunol Immunopathol 1997;84:223-43.
2. Bynoe MS, Grimaldi CM, Diamond B. Estrogen up-regulates Bcl-2 and block tolerance induction of naive B cells. Immunology 2000;97:2703-8.
3. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
4. Vlahakos D, Foster MH, Clcci AA et al. Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei and induce glomerular proliferation and proteinuria in vivo. J Am Soc Nephrol 1992;2:1345-54.
5. Weidler C, Harle P, Schedel J, Schmidt M, Scholmerich J, Straub RH. Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogen in relation to endogenous antiestrogens. J Rheumatol 2004;31:489-94.
6. Lahita RG, Bradlow HL, Kunal HG, Fishman J. Alteration of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum 1979;22:1195-8.
7. Castagnetta L, Cutolo M, Granata O, Di Falco M, Bellavia V, Carruba G. Endocrine end points in rheumatoid arthritis. Ann N Y Acad Sci 1999;876:180-92.
8. Castagnetta L, Carruba G, Granata OM et al. Increased estrogen formation and estrogen to endrogen ratio in the SF of patients with rheumatoid arthritis. J Rheumatol 2003;30:2597-605.
9. Gilkerson GS, Cannon C, Oates JC. Correlation of serum measures of nitric oxide production with lupus disease activity. J Rheumatol 1999;26:318-24.
10. Belmont HM, Levartovsky D, Goel A. Increased nitric oxide production accompanied by the up regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:1810-6.
11. Rollar G, Brussiono L, Bertero MT. Increased nitric oxide in exhaled air of patients with systemic lupus erythematosus. J Rheumatol 1997;19:1066-71.
12. Grossman C. Interactions between the gonadal steroids and the immune system. Science 1985;227:257-61.
13. Grossman C, Roselle G, Mendenhall C. Sex steroid regulation of autoimmunity. J Steroid Biochem Mol Biol 1991;40:649-59.
14. Lahita RG, Bradlow HL, Ginzler E et al. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987;30:241-8.
15. Kanda N, Tamaki K. Estrogen enhances of immunoglobulin production by human peripheral blood mononuclear cells. J Allergy Clin Immunol 1999;103:328-37.
16. Roubinian J, Talal N, Siiteri PK, Sadakian JA. Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum 1979;22:1162-9.
17. Mansoor F, Ali A, Ali R. Binding of circulating SLE autoantibodies to oxygen free radical damage chromatin. Autoimmunity 2005;38:431-8.
18. Alam K, Ali R. Human anti-DNA autoantibodies and induced antibodies against ROS-modified DNA show similar antigen binding characteristics. Biochem Mol Biol Int 1999;47:881-9.
19. Gark DK, Moinuddin, Ali R. Hydroxyl modification of polyguanilic acid: role of modified guanine in circulating SLE anti-DNA autoantibodies. Immunol Invest 2003;32:187-99.
20. Waris G, Alam K. Immunogenicity of superoxide radical modified-DNA: studies on induced antibodies and SLE anti-DNA autoantibodies. Life Sci 2004;75:2633-42.
21. Dixit K, Moinuddin, Ali A. Immunological studies on peroxynitrite modified human DNA. Life Sci 2005;77:2626-42.
22. Habib S, Moinuddin, Ali R. Acquired antigenicity of DNA after modification with peroxynitrite. Int J Biol Macromol 2005;35:221-5.
23. Arnett FC, Edworthy TA, Kaplan SR et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
24. Yoshie Y, Ohshima H. Synergestic induction of DNA strand breakage by catechol-estrogens and nitric oxide: implication for hormonal carcinogenesis. Free Radic Biol Med 1998;24:341-8.
25. Hasan R, Ali R. Antibody recognition of common epitopes on Z-DNA and native DNA brominated under high salt. Biochem Int 1990;20:1077-88.
26. Ali R, Alam K. Evaluation of antibodies against free radical modified DNA by ELISA. In: Armstrong D, ed. Oxidative Stress Biomarkers and Antioxidants Protocols. New Jersey: Human Press, 2002:171-81.
27. Dixit K, Ali R. Antigen binding characteristics of antibodies induced against nitric oxide modified plasmid DNA. Biochim Biophys Acta 2001;1528:1-8.
28. Burton K. A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 1956;62:315-23.
29. Bradford MM. A rapid and sensitive method for quantitation of micrograms quantity of protein utilizing the principle of protein dye binding. Anal Biochem 1976;72:248-54.
30. Langmuir I. The adsorption of gases on plane surface glass, mica and platinum. J Am Chem Soc 1918;40:1361-403.
31. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003;56:481-90.
32. Pollard KM, Joyee JE, Tan EM, Theofilopoules AM, Dixon FJ, Rubin RL. Polynucleotide specificities of murine monoclonal anti-DNA antibodies. Clin Immunol Immunopathol 1986;40:197-208.
33. Jansson G. Formation of antibodies to native DNA in rats after administration of native DNA treated with xanthine-xanthine oxidase system. Free Radic Res Commun 1985;1:119-22.
34. Cervera R, Khamashta MA, Fon J et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993;72:113-24.
35. Liehr JG. Is estradiol a genotoxic mutagenic carcinogens? Endocr Rev 2000;21:40-54.
36. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogen as endogenous genotoxic agents-DNA adducts and mutation. J Natl Cancer Inst Monogr 2000;27:75-93.
37. Ho CY, Wong CK, Li EK, Tam LS, Lam CW. Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus. Rheumatology 2003;43:117-22.
38. Oates JS, Ruiz P, Alexander A. Effects of late modulation of nitric oxide production on murine lupus. Clin Immunol Immunopathol 1997;83:86-92.
39. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998;19:1-27.
40. Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT. Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995;13:217-26.